1 |
M. K. Garg, M. K. Dutta & N. Mahalle. (2011). Study of beta-cell function (by HOMA model) in metabolic syndrome. Indian Journal of Endocrinology and Metabolism, 15(1), 44-49. DOI : 10.4103/2230-8210.83059
DOI
|
2 |
J. B. Dixon, A. F. Dixon & P. E. O'Brien. (2003). Improvements in insulin sensitivity and beta-cell function(HOMA) with weight loss in the severely obese. Homeostatic model assessment. Diabetic Medicine, 20(2), 127-134. DOI : 10.1046/j.1464-5491.2003.00889.x
DOI
|
3 |
H. H. Sung et al. (2020). The association of the visceral adiposity index with insulin resistance and beta-cell function in Korean adults with and without type 2 diabetes mellitus. Endocrine Journal, 12. DOI : 10.1507/endocrj.EJ19-0517
|
4 |
E. Ferrannini. (1998). Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects. Endocrine Reviews, 19(4), 477-490. DOI : 10.1210/edrv.19.4.0336
DOI
|
5 |
M. Kasuga. (2006). Insulin resistance and pancreatic beta cell failure. Journal of Clinical Investigation, 116(7), 1756-1760. DOI : 10.1172/JCI29189
DOI
|
6 |
S. E. Kah, R. L. Hull & K. M. Utzschneider. (2006). Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature, 444(7121), 840-846. DOI : 10.1038/nature05482
DOI
|
7 |
K. M. Knowles et al. (2011). Waist circumference, body mass index, and other measures of adiposity in predicting cardiovascular disease risk factors among Peruvian adults. International Journal of Hypertension, 24, 931402. DOI : 10.4061/2011/931402
|
8 |
D. Canoy et al. (2007). Body fat distribution and risk of coronary heart disease in men and women in the European prospective investigation into cancer and nutrition in Norfolk Cohort: a population-based prospective study. Circulation, 116(25), 2933-2943. DOI : 10.1161/CIRCULATIONAHA.106.673756
DOI
|
9 |
M. Lee & L. J. Aronne. (2007). Weight management for type 2 diabetes mellitus: global cardiovascular risk reduction. American Journal of Cardiology, 99(4), 68-79. DOI : 10.1016/j.amjcard.2006.11.007
DOI
|
10 |
A. Shuster, M. Patlas, J. H. Pinthus & M. Mourtzakis. (2012). The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis. The British Journal of Radiology, 85(1009), 1-10. DOI : 10.1259/bjr/38447238
DOI
|
11 |
M. C. Pouliot et al. (1994). Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. American Journal of Cardiology, 73(7), 460-468. DOI : 10.1016/0002-9149(94)90676-9
DOI
|
12 |
M. C. Amato et al. (2010). Visceral adiposity index: a reliable indicator of visceral fat function associated with cardiometabolic Risk. Diabetes Care, 33(4), 920-922. DOI : 10.2337/dc09-1825
DOI
|
13 |
S. E. Kahn. (2003). The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia, 46(1), 3-19. DOI : 10.1007/s00125-002-1009-0
DOI
|
14 |
T. Du, X. Sun, R. Huo & X. Yu. (2014). Visceral adiposity index, hypertriglyceridemic waist and risk of diabetes: the china health and nutrition survey 2009. International Journal of Obesity, 38(6), 840-847. DOI : 10.1038/ijo.2013.181
DOI
|
15 |
J. Y. Oh, Y. A. Sung & H. J. Lee. (2013). The visceral adiposity index as a predictor of insulin resistance in young women with polycystic ovary syndrome. Obesity (Silver Spring), 21(8), 1690-1694. DOI : 10.1002/oby.20096
DOI
|
16 |
G. A. Balsan, J. L. da Costa Vieira, A. M. de Oliveira & V. L. Portal. (2015). Relationship between adiponectin, obesity and insulin resistance. Revista da Associacao Medica Brasileira (1992), 61(1), 72-80. DOI : 10.1590/1806-9282.61.01.072
DOI
|
17 |
G. Kloppel, M. Lohr, K. Habich, M. Oberholzer & P. U. Heitz. (1985). Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Survey and Synthesis of Pathology Research, 4(2), 110-125. DOI : 10.1159/000156969
|
18 |
B. L. Wajchenberg. (2007). Beta-cell failure in diabetes and preservation by clinical treatment. Endocrine Reviews, 28(2), 187-218. DOI : 10.1210/10.1210/er.2006-0038
DOI
|
19 |
D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher & R. C. Turner. (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28(7), 412-419. DOI : 10.1007/BF00280883
DOI
|
20 |
S. Cernea & M. Dobreanu. (2013). Diabetes and beta cell function: from mechanisms to evaluation and clinical implications. Biochemia Medica, 23(3), 266-280. DOI : 10.11613/bm.2013.033
|
21 |
K. A. Shin & Y. J. Kim. (2019). Usefulness of surrogate markers of body fat distribution for predicting metabolic syndrome in middle-aged and older Korean populations. Diabetes, Metabolic Syndrome and Obesity, 12, 2251-2259. DOI : 10.2147/DMSO.S217628
DOI
|
22 |
M. Bozorgmanesh, F. Hadaegh & F. Azizi. (2010). Predictive performances of lipid Accumulation product vs. adiposity measures for cardiovascular diseases and all-cause mortality, 8.6-year follow-up: tehran lipid and glucose study. Lipids in Health and Disease, 16(9), 100. DOI : 10.1186/1476-511X-9-100
|
23 |
N. M. Al-Daghri et al. (2013). Visceral adiposity index is highly associated with adiponectin values and glycaemic disturbances. European Journal of Clinical Investigation, 43(2), 183-189. DOI : 10.1111/eci.12030
DOI
|
24 |
M. Stepien et al. (2014). New obesity indices and adipokines in normotensive patients and patients with hypertension: comparative pilot analysis. Angiology, 65(4), 333-342. DOI : 10.1177/0003319713485807
DOI
|
25 |
S. W. Oh, S. A. Shin, Y. H. Yun, T. W. Yoo & B. Y. Huh. (2004). Cut-off point of BMI and obesity-related comorbidities and mortality in middle-aged Koreans. Obesity Research, 12(12), 2031-2040. DOI : 10.1038/oby.2004.254
DOI
|
26 |
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. (2001). Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). The Journal of the American Medical Association, 285(19), 2486-2497. DOI : 10.1001/jama.285.19.2486
DOI
|
27 |
E. E. Calle & R. Kaaks. (2004). Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nature Reviews Cancer, 4(8), 579-591. DOI : 10.1038/nrc1408
DOI
|
28 |
World Health Organization. (2000). The Asia-Pacific perspective: redefining obesity and its treatment. Sydney : Health Communications Australia.
|
29 |
S. Lee et al. (2006). Cutoff values of surrogate measures of insulin resistance for metabolic syndrome in Korean non-diabetic adults. Journal of Korean Medical Science, 21(4), 695-700. DOI : 10.3346/jkms.2006.21.4.695
DOI
|
30 |
Y. Song et al. (2007). Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: the women's health initiative observational study. Diabetes Care, 30(7), 1747-1752. DOI : 10.2337/dc07-0358
DOI
|
31 |
B. M. Popkin, L. S. Adair & S. W. Ng. (2012). Global nutrition transition and the pandemic of obesity in developing countries. Nutrition Reviews, 70(1), 3-21. DOI : 10.1111/j.1753-4887.2011.00456.x
DOI
|
32 |
J. P. Despres & I. Lemieux. (2006). Abdominal obesity and metabolic syndrome. Nature, 444(7121), 881-887. DOI : 10.1038/nature05488
DOI
|
33 |
E. Mazzuca et al. (2014). Gender-specific anthropometric markers of adiposity, metabolic syndrome and visceral adiposity index (VAI) in patients with obstructive sleep apnea. Journal of Sleep Research, 23(1), 13-21. DOI : 10.1111/jsr.12088
DOI
|
34 |
B. Elisha et al. (2013). The visceral adiposity index: relationship with cardiometabolic risk factors in obese and overweight postmenopausal women-a MONET group study. Applied Physiology, Nutrition, and Metabolism, 38(8), 892-899. DOI : 10.1139/apnm-2012-0307
DOI
|
35 |
N. S. Kalupahana & N. Moustaid-Moussa. (2012). The renin-angiotensin system: a link between obesity, inflammation and insulin resistance. Obesity Reviews, 13(2), 136-149. DOI : 10.1111/j.1467-789X.2011.00942.x
DOI
|
36 |
L. Ramalingam et al. (2017). The renin angiotensin system, oxidative stress and mitochondrial function in obesity and insulin resistance. Biochimica et Biophysica Acta-Molecular Basis of Disease, 1863(5), 1106-1114. DOI : 10.1016/j.bbadis.2016.07.019
DOI
|